Literature DB >> 12594845

Naive CD8+ T cell recruitment and proliferation are dependent on stage of dendritic cell maturation.

Andrew Kaiser1, Nadège Bercovici, Jean-Pierre Abastado, Alessandra Nardin.   

Abstract

Dendritic cells (DC) play a crucial role in controlling the initiation and orientation of antigen (Ag)-specific immune responses. It is widely accepted that optimal T cell priming requires mature DC. Although the molecular events associated with DC activation have been extensively studied, little is known about the consequences of DC maturation on recruitment and expansion of naive T cells. In the present study, we used a model tumor Ag to show that the kinetics of human DC maturation drastically affect the induction of Ag-specific effector CD8(+) T cells. In absence of exogenous cytokines and CD4 help, only DC at early stages of maturation were able to generate high frequencies of CTL. This expansion resulted from both enhanced recruitment and intense proliferation ofT cell precursors and could lead to an increase of up to 1,000-fold in the final number of effector T cells compared to non-matured DC. In our model, larger recruitment of naïve CD8(+) cells did not modify the overall avidity of the Ag-specific T cell population.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12594845     DOI: 10.1002/immu.200390019

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  3 in total

1.  Immunogenicity of liposomes containing lipid core peptides and the adjuvant Quil A.

Authors:  Karen White; Thomas Rades; Philip Kearns; Istvan Toth; Sarah Hook
Journal:  Pharm Res       Date:  2006-06-21       Impact factor: 4.200

2.  Toll-like receptor 4 engagement drives differentiation of human and murine dendritic cells from a pro- into an anti-inflammatory mode.

Authors:  Romana Luger; Sneha Valookaran; Natalie Knapp; Caterina Vizzardelli; Alexander M Dohnal; Thomas Felzmann
Journal:  PLoS One       Date:  2013-02-11       Impact factor: 3.240

3.  Audencel Immunotherapy Based on Dendritic Cells Has No Effect on Overall and Progression-Free Survival in Newly Diagnosed Glioblastoma: A Phase II Randomized Trial.

Authors:  Johanna Buchroithner; Friedrich Erhart; Josef Pichler; Georg Widhalm; Matthias Preusser; Günther Stockhammer; Martha Nowosielski; Sarah Iglseder; Christian F Freyschlag; Stefan Oberndorfer; Karin Bordihn; Gord von Campe; Markus Hoffermann; Reinhard Ruckser; Karl Rössler; Sabine Spiegl-Kreinecker; Michael B Fischer; Thomas Czech; Carmen Visus; Günther Krumpl; Thomas Felzmann; Christine Marosi
Journal:  Cancers (Basel)       Date:  2018-10-05       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.